Science Daily1d
New therapy may effectively control HIV in Uganda
A multi-national, multi-institutional study investigators found little natural resistance to a new HIV therapy called lenacapavir in a population of patients in Uganda.
News Medical on MSN2d
New HIV therapy lenacapavir shows high efficacy in Ugandan population
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Trump's foreign aid freeze halted a crucial program fighting HIV in Africa. Here's what's at stake
The freeze on U.S. foreign aid ordered by President Donald Trump has effectively halted one of the world's most successful ...
South Africa has more people living with HIV than any other country. Trump’s aid freeze has hit hard
In the rural villages of South Africa, U.S. President Donald Trump’s sudden freeze on foreign aid impacts hundreds of ...
CNN on MSN9d
‘Some of the things that I say will be incorrect’: Musk backs away from false claim of $50 million for Gaza condoms
Elon Musk acknowledged Tuesday that there might not have been a federal plan to spend $50 million on condoms for Gaza – two ...
The Washington Post5d
South African NGOs worry Trump's aid freeze will cause HIV patients to default on treatment
Majola is one of millions of patients in South Africa affected by U.S. President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection ...
Drug therapy lenacapavir may effectively control HIV in Uganda
A multi-national, multi-institutional study led by Weill Cornell Medicine investigators found little natural resistance to a ...
Politico5d
South Africans worry Trump’s aid freeze will cause HIV patients to default on treatment
Majola is one of millions of patients in South Africa affected by President Donald Trump’s global foreign aid freeze, raising worries about HIV patients defaulting on treatment, infection rates ...